
Loading, please wait...

Loading, please wait...

The rapid development of flexible aqueous zinc-sulfur batteries represents a significant milestone in miniaturized energy storage for wearable medical devices. Using CO2 laser-assisted graphitization, researchers have successfully created binder-free electrodes that enable customizable patterning for microelectronics. This inaugural demonstration of in-plane zinc-sulfur cells suggests a future where medical monitors are thinner and more adaptable than ever before.
The researchers utilized a unique sublimation-transport-desublimation process to trap elemental sulfur within a laser-induced graphene (LIG) matrix. This method achieved a high sulfur content of approximately 58%. Furthermore, the covalent bonding between sulfur and LIG defect sites ensures a stable, binder-free electrode. Although soluble sulfates initially caused capacity fading, the team successfully mitigated this issue using a gel polymer electrolyte. Moreover, this semi-solid-state prototype demonstrates impressive electrochemical performance.
These batteries deliver an impressive capacity of 59 µAh/cm² and maintain performance over 80 cycles. Because aqueous electrolytes are inherently safer and non-flammable, they are ideal candidates for skin-integrated health monitors. For instance, this technology could lead to safer, long-lasting power sources for continuous glucose monitors or cardiac patches. Consequently, engineers can now design miniaturized energy storage without sacrificing patient safety or device flexibility.
They use aqueous electrolytes, which are non-flammable and safer for skin-contact devices compared to traditional lithium-ion batteries.
Laser treatment enables rapid, binder-free patterning of graphene. This allows for miniaturized and flexible designs suitable for micro-electronics.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Thippeswamy P et al. Laser Assisted Rapid Prototyping of In-Plane, Flexible, Rechargeable Aqueous Zn-S Batteries. Small. 2026 Feb 15. doi: 10.1002/smll.202511993. PMID: 41691639.
Wang W et al. Flexible Quasi-Solid-State Aqueous Zinc-Ion Batteries: Design Principles, Functionalization Strategies, and Applications. ResearchGate. 2021.
Wu ZS et al. High-safety, Flexible and Scalable Zn//MnO2 Rechargeable Planar Micro-batteries. National Science Review. 2019.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study presents a laser-assisted method for fabricating flexible zinc-sulfur batteries, offering safer power solutions for future medical wearables....
8 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today